Opioid therapy for chronic pain: Difference between revisions
Jump to navigation
Jump to search
(/* Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT){{cite web |u...) |
(/* Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT){{cite web |u...) |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
===Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT)<ref name="urlNational Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain.">{{cite web |url=http://www.guideline.gov/content.aspx?id=16313&search=opioid+therapy+guidelines |title=National Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. |format= |work= |accessdate=2012-11-28}}</ref>=== | ===Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT) <ref name="urlNational Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain.">{{cite web |url=http://www.guideline.gov/content.aspx?id=16313&search=opioid+therapy+guidelines |title=National Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. |format= |work= |accessdate=2012-11-28}}</ref>=== | ||
{| | ===Recommendations for assessment of patients with chronic pain(DO NOT EDIT) <ref name="urlNational Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain.">{{cite web |url=http://www.guideline.gov/content.aspx?id=16313&search=opioid+therapy+guidelines |title=National Guideline Clearinghouse | VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. |format= |work= |accessdate=2012-11-28}}</ref>=== | ||
Recommendations | {|class="wikitable" | ||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' ASD should be diagnosed by imaging techniques with demonstration of shunting across the defect and evidence of RV volume overload and any associated anomalies. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' Patients with unexplained RV volume overload should be referred to an ACHD center for further diagnostic studies to rule out obscure ASD, partial anomalous venous connection, or coronary sinoseptal defect.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |} | ||
Revision as of 11:25, 28 November 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT) [1]
Recommendations for assessment of patients with chronic pain(DO NOT EDIT) [1]
| Class I |
| "1. ASD should be diagnosed by imaging techniques with demonstration of shunting across the defect and evidence of RV volume overload and any associated anomalies. (Level of Evidence: C) " |
| "2. Patients with unexplained RV volume overload should be referred to an ACHD center for further diagnostic studies to rule out obscure ASD, partial anomalous venous connection, or coronary sinoseptal defect.(Level of Evidence: C)" |